Trials / Completed
CompletedNCT04857099
Impact of the Navilas ® Micropulse Laser Treatment for Macular Edema Within the CHU Brugmann Hospital Macular Edema
Retrospective Study Within the Brugmann University Hospital of the Navilas ® Micropulse Laser Treatment for Macular Edema
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 23 (actual)
- Sponsor
- Brugmann University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Navilas® micropulse laser can be used to treat patients with macular edema and good visual acuity, which therefore do not fall within the indications for conventional treatments by intravitreal injections. The CHU Brugmann Hospital is the only center to own this laser in Belgium.This study aims to evaluate the efficacy of this laser.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data extraction from medical files | Data extraction from medical files |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2021-09-22
- Completion
- 2021-09-22
- First posted
- 2021-04-23
- Last updated
- 2022-03-08
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04857099. Inclusion in this directory is not an endorsement.